Dr. Lieven Ameye: what changed
What changed
Dr. Lieven Ameye
NACE 86.220, Specialist medical practice
filed annual accounts (NBB)
Net result for the year
€423,250
2024 · €391,913+€31,337
Equity
€151,322
2024 · €28,072+€123,250
Cash
€435,352
2024 · €151,709+€283,643
Balance sheet total
€541,820
2024 · €1.0m-€498,105
Largest movements
Assets
- Receivables after one year -€500,000
no longer reported in 2025 (was €500,000)
- Cash +€283,643
up €283,643 (+187%), from €151,709 to €435,352
mainly Receivables after one year (+€500,000) and Net result for the year (+€423,250)
- Current investments -€280,000
no longer reported in 2025 (was €280,000)
Equity and liabilities
- Other debts -€631,255
down €631,255 (-62.4%), from €1.0m to €380,599
- Reserves +€123,250
up €123,250 (+512%), from €24,072 to €147,322
Income statement
- Gross operating margin +€52,394
up €52,394 (+10.7%), from €489,901 to €542,295
- Taxes +€16,473
up €16,473 (+13.1%), from €125,970 to €142,443
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€391,913
Gross operating margin
+€52,394
Depreciation
+€99
Other operating charges
-€16
Financial income
-€4,660
Financial charges
-€6
Taxes
-€16,473
Result 2025
€423,250
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€311,209
Investment
+€272,434
Financing
-€300,000
Cash 2024
€151,709
From operations (derived)
+€311,209
Net result for the year
+€423,250
Depreciation
+€425
Receivables after one year
+€500,000
Receivables within one year
+€5,139
Deferred charges and accrued income
+€3,750
Tax, wage and social debts
+€9,899
Other debts
-€631,255
Investment (derived)
+€272,434
Investment in fixed assets (net)
-€7,566
Current investments
+€280,000
Financing
-€300,000
Contributions, distributions and other
-€300,000
Cash 2025
€435,352
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,039,925 | €541,820 | -€498,105 | -47.9% |
| Fixed assets | 21/28 | €139 | €7,280 | +€7,140 | +5,121% |
| Tangible fixed assets | 22/27 | €139 | €7,280 | +€7,140 | +5,121% |
| Furniture and vehicles | 24 | €139 | €7,280 | +€7,140 | +5,121% |
| Current assets | 29/58 | €1,039,786 | €534,540 | -€505,246 | -48.6% |
| Amounts receivable after more than one year | 29 | €500,000 | - | -€500,000 | |
| Other amounts receivable | 291 | €500,000 | - | -€500,000 | |
| Amounts receivable within one year | 40/41 | €76,258 | €71,118 | -€5,139 | -6.7% |
| Trade receivables | 40 | €58,322 | €65,887 | +€7,565 | +13.0% |
| Other amounts receivable | 41 | €17,936 | €5,231 | -€12,704 | -70.8% |
| Current investments | 50/53 | €280,000 | - | -€280,000 | |
| Cash at bank and in hand | 54/58 | €151,709 | €435,352 | +€283,643 | +187% |
| Deferred charges and accrued income | 490/1 | €31,820 | €28,070 | -€3,750 | -11.8% |
| Total equity and liabilities | 10/49 | €1,039,925 | €541,820 | -€498,105 | -47.9% |
| Equity | 10/15 | €28,072 | €151,322 | +€123,250 | +439% |
| Contributions | 10/11 | €4,000 | €4,000 | = | 0.0% |
| Reserves | 13 | €24,072 | €147,322 | +€123,250 | +512% |
| Distributable reserves | 133 | €24,072 | €147,322 | +€123,250 | +512% |
| Amounts payable | 17/49 | €1,011,853 | €390,498 | -€621,355 | -61.4% |
| Amounts payable within one year | 42/48 | €1,011,853 | €390,498 | -€621,355 | -61.4% |
| Taxes, remuneration and social security | 45 | - | €9,899 | +€9,899 | |
| Taxes | 450/3 | - | €9,899 | +€9,899 | |
| Other amounts payable | 47/48 | €1,011,853 | €380,599 | -€631,255 | -62.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €525 | €425 | -€99 | -18.9% |
| Other operating charges | 640/8 | €528 | €544 | +€16 | +3.0% |
| Gross operating margin | 9900 | €489,901 | €542,295 | +€52,394 | +10.7% |
| Operating profit (loss) | 9901 | €488,848 | €541,325 | +€52,477 | +10.7% |
| Financial income | 75/76B | €29,045 | €24,385 | -€4,660 | -16.0% |
| Recurring financial income | 75 | €29,045 | €24,385 | -€4,660 | -16.0% |
| Financial charges | 65/66B | €11 | €17 | +€6 | +60.5% |
| Recurring financial charges | 65 | €11 | €17 | +€6 | +60.5% |
| Profit (loss) for the period before taxes | 9903 | €517,883 | €565,693 | +€47,811 | +9.2% |
| Income taxes | 67/77 | €125,970 | €142,443 | +€16,473 | +13.1% |
| Profit (loss) for the period | 9904 | €391,913 | €423,250 | +€31,337 | +8.0% |
| Profit (loss) for the period to be appropriated | 9905 | €391,913 | €423,250 | +€31,337 | +8.0% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 1 November 2026 via checked.be.